PP
DSCI

Paloma Partners’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Paloma Partners’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-34,900
Closed -$250K – 2301
2015
Q2 		$250K Buy
+34,900
New +$262K ﹤0.01% 1435

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Paloma Partners's DSCI Position: Q3 2015 in Review

Paloma Partners sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2015, closing a stake of 34,900 shares — an estimated $250K sold.

Paloma Partners first reported a position in DSCI in Q2 2015 and held it in 1 quarter. The position peaked at $250K in Q2 2015. 55 funds tracked by Wall St. Rank hold DSCI as of Q3 2015.

  • Paloma Partners reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2015 after selling out during the quarter.
  • Paloma Partners sold 34,900 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2015, an estimated $250K.
  • Paloma Partners first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2015 and held it in 1 quarter.
  • Paloma Partners's Derma Sciences, Inc. Common Stock (DE) position peaked at $250K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2015.

Based on Paloma Partners's 13F filing for Q3 2015, filed 16 Nov 2015.